Lördag 12 September | 05:00:23 Europe / Stockholm
Est. tid*
2026-11-12 07:00 Kvartalsrapport 2026-Q3
2026-08-19 - Kvartalsrapport 2026-Q2
2026-05-15 - Kvartalsrapport 2026-Q1
2026-04-24 - X-dag ordinarie utdelning LIFE 0.00 NOK
2026-04-23 - Årsstämma
2026-03-03 - Bokslutskommuniké 2025
2026-01-02 - Extra Bolagsstämma 2026
2025-11-12 - Extra Bolagsstämma 2025
2025-11-12 - Kvartalsrapport 2025-Q3
2025-08-20 - Kvartalsrapport 2025-Q2
2025-05-15 - Kvartalsrapport 2025-Q1
2025-04-28 - X-dag ordinarie utdelning LIFE 0.00 NOK
2025-04-25 - Årsstämma
2025-02-20 - Bokslutskommuniké 2024
2024-11-13 - Kvartalsrapport 2024-Q3
2024-10-01 - Split LIFE 13:1
2024-08-27 - Kvartalsrapport 2024-Q2
2024-05-16 - Extra Bolagsstämma 2024
2024-05-08 - Kvartalsrapport 2024-Q1
2024-05-02 - X-dag ordinarie utdelning LIFE 0.00 NOK
2024-04-30 - Årsstämma
2024-02-27 - Bokslutskommuniké 2023
2023-11-14 - Kvartalsrapport 2023-Q3
2023-08-23 - Kvartalsrapport 2023-Q2
2023-05-11 - Kvartalsrapport 2023-Q1
2023-05-08 - X-dag ordinarie utdelning LIFE 0.00 NOK
2023-04-18 - Årsstämma
2023-02-28 - Bokslutskommuniké 2022
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-09 - X-dag ordinarie utdelning LIFE 0.00 NOK
2022-05-06 - Årsstämma
2022-04-21 - Bokslutskommuniké 2021
2021-09-30 - Extra Bolagsstämma 2021
2021-08-05 - Kvartalsrapport 2021-Q2
2021-05-10 - X-dag ordinarie utdelning LIFE 0.00 NOK
2021-05-07 - Årsstämma
2021-04-20 - Bokslutskommuniké 2020
2020-06-26 - Årsstämma
2020-06-01 - Bokslutskommuniké 2019
2019-02-07 - Split LIFE 4:1
2018-12-11 - Extra Bolagsstämma 2018
LandNorge
ListaOslo Bors
SektorHälsovård
IndustriMedicinteknik
Lifecare är ett norskt bolag verksamt inom medicinteknik. Bolaget är specialiserat inom forskning och utveckling av microsensorer för diabetes. Mikrosensorerna injiceras under huden på patientens handled, och fungerar vidare som en realtidsuppdatering av glukosnivån i patienten. Utöver bidrar tekniken med larmsensor samt tillgång till historisk data över patientens glukosnivå. Bolaget etablerades under 2006 och har sitt huvudkontor i Bergen, Norge.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Lifecare ASA – Completion of Acquisition of Ocean TuniCell AS and Issuance of Consideration Shares

2026-09-11 21:04:00

Bergen, Norway, 11 September 2026: Reference is made to the stock exchange announcement by Lifecare ASA (ticker: LIFE) ("Lifecare" or the "Company") dated 31 August 2026 regarding the agreement to acquire 80% of the shares in Ocean TuniCell AS ("Ocean TuniCell").

All conditions for completion of the transaction have been satisfied or waived and the Transaction has today been completed.

Lifecare ASA has offered the remaining shareholders in Ocean TuniCell the opportunity to sell their shares to Lifecare on corresponding financial terms, and Lifecare has received acceptance forms for an additional 6.6% of Ocean TuniCell’s shares. Closing of these purchases took place simultaneously with closing of the original agreement.

As a result, Lifecare has acquired a total of 86.7% of the shares in Ocean TuniCell AS.

In connection with completion of these share purchases, the Board of Directors of Lifecare has today resolved, pursuant to the authorization granted by the Annual General Meeting held on 23 April 2026, to increase the Company's share capital through the issuance of 22,650,489 new shares at a subscription price of NOK 0.287136 per share.

These consideration shares constitute the entire initial consideration for the shares acquired in Ocean TuniCell. For further information regarding a potential additional contingent consideration, please see the Company's announcement dated 31 August 2026.

The subscription price for the consideration shares was determined by the Board of Directors based on the volume weighted average price (“VWAP”) of the Lifecare share over the 15 trading days immediately preceding the valuation date, in accordance with the transaction documentation.

Following registration of the share capital increase with the Norwegian Register of Business Enterprises, Lifecare's share capital will be NOK 43,036,196.00, divided into 430,361,960 shares, each with a nominal value of NOK 0.10.

The share capital increase will be filed for registration with the Norwegian Register of Business Enterprises as soon as all required documentation has been completed, and the consideration shares will be delivered through VPS following such registration.

20,914,068 of the consideration shares are subject to lock-up obligations for a period of nine months from completion of the transaction on the terms and conditions of the share purchase agreement.